MARKET

IQV

IQV

Iqvia Hldgs Inc
NYSE
215.28
+0.29
+0.13%
After Hours: 215.28 0 0.00% 16:20 12/08 EST
OPEN
214.39
PREV CLOSE
214.99
HIGH
216.22
LOW
213.37
VOLUME
603.94K
TURNOVER
0
52 WEEK HIGH
241.86
52 WEEK LOW
167.42
MARKET CAP
39.29B
P/E (TTM)
36.12
1D
5D
1M
3M
1Y
5Y
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt
Iqvia holdings inc. (nyse:iqv) uses debt to fund its business. Iqvia's debt is 4.5 times its ebitda, but the company does not appear to be in trouble with its debt levels. The company's net debt is us$13.6b, but it has us$1.33b in cash and short-term receivables. Debt is a key factor in assessing a company's risk, but iqvia's debt levels are not problematic. Iqvia's free cash flow is higher than its debt, but this doesn't mean it's in trouble.
Simply Wall St · 1d ago
IQVIA (IQV) Stock Gains 8% in a Month: Here's What to Know
NASDAQ · 2d ago
Iqvia Hldgs Inc: Statement of changes in beneficial ownership of securities
Press release · 4d ago
Veeva Systems: Attractively Valued FCF Star
Veeva systems provides cloud solutions for the life sciences industry. Veeva has shown exceptional financial performance with strong revenue growth and operating leverage. The company has no debt and a large net cash position. Iqv is a direct competitor, but the company's offerings are much more appealing. My valuation analysis suggests veev is attractively valued.
Seeking Alpha · 5d ago
Weekly Report: what happened at IQV last week (1127-1201)?
Weekly Report · 6d ago
Iqvia Hldgs Inc: Report of proposed sale of securities
Press release · 12/01 22:15
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)
TipRanks · 12/01 13:30
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q3 2023 Update
Duquesne family office's 13f portfolio value decreased by 3% to $2.79b in q3 2023. The largest five stakes are nvidia, coupang, microsoft, eli lilly, and teck resources. New stakes include alphabet, vistra corp, seagate tech, and broadcom.
Seeking Alpha · 12/01 00:47
More
About IQV
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Webull offers Iqvia Holdings Inc stock information, including NYSE: IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.